David R. Bauer
Lawyers
Filters
Tempus AI $500 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
GSK agreements with Hengrui Pharma to develop up to 12 innovative medicines
We are advising GSK on the transaction
Tempus AI $750 million convertible senior notes offering
The 0.75% convertible senior notes are due 2030
SiTime $402.5 million follow-on offering
The shares are listed on the Nasdaq Global Market
Omada Health $172.6 million IPO
The shares are listed on the Nasdaq Global Select Market
Hinge Health $503 million IPO
The shares are listed on the New York Stock Exchange
Qualcomm $1.5 billion notes offering
The investment-grade notes are due 2030, 2032 and 2035
Atara Biotherapeutics registered direct offering
The stock is listed on Nasdaq
Biogen $1.75 billion senior notes offering
The investment-grade notes are due 2031, 2035 and 2055
Insulet $450 million senior notes offering
The high-yield notes are due 2033